Back

c-di-AMP hydrolysis by a novel type of phosphodiesterase promotes differentiation of multicellular bacteria

Latoscha, A.; Drexler, D. J.; Al-Bassam, M. M.; Kaever, V.; Findlay, K. C.; Witte, G.; Tschowri, N.

2019-10-01 microbiology
10.1101/789354 bioRxiv
Show abstract

Antibiotic-producing Streptomyces use the diadenylate cyclase DisA to synthesize the nucleotide second messenger c-di-AMP but the mechanism for terminating c-di-AMP signaling and the proteins that bind the molecule to effect signal transduction are unknown. Here, we identify the AtaC protein as a new type of c-di-AMP-specific phosphodiesterase that is also conserved in pathogens such as Streptococcus pneumoniae and Mycobacterium tuberculosis. AtaC is monomeric in solution and binds Mn2+ to specifically hydrolyze c-di-AMP to AMP via the intermediate 5-pApA. As an effector of c-di-AMP signaling, we characterize the RCK-domain protein CpeA as the first c-di-AMP-binding protein to be identified in Streptomyces. CpeA interacts with the predicted cation / proton antiporter, CpeB, linking c-di-AMP signaling to ion homeostasis in actinobacteria. Hydrolysis of c-di-AMP is critical for normal growth and differentiation in Streptomyces, connecting osmotic stress to development. Thus, we present the discovery of two novel components of c-di-AMP signaling in bacteria and show that precise control of this second messenger is essential for osmoregulation and coordinated development in Streptomyces.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.